Recommended Antibiotic for Dual Infections with Augmentin Rash
For a patient with both a pedicure-related toe infection and a deep-seated dental infection who develops a rash to Augmentin, switch to clindamycin 300 mg orally three times daily for 5-7 days, as it provides excellent coverage for both skin/soft tissue infections and odontogenic infections while avoiding the penicillin/beta-lactam class entirely.
Rationale for Clindamycin
The rash from Augmentin necessitates avoiding all beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) until the allergy can be properly characterized. Clindamycin emerges as the optimal alternative because:
- Dual coverage: It has excellent activity against staphylococci, streptococci, and anaerobes—the primary pathogens in both skin/soft tissue infections from pedicure trauma and odontogenic infections 1
- Guideline-supported: The IDSA skin and soft tissue infection guidelines specifically list clindamycin (300 mg TID orally or 600 mg every 6-8 hours IV) as an appropriate alternative for bite wounds and soft tissue infections 1
- Dental infection efficacy: Multiple studies confirm clindamycin's effectiveness for odontogenic infections, with one randomized trial showing comparable clinical success rates (89.7%) to amoxicillin-clavulanate (88.2%) 2
Coverage Considerations
What Clindamycin Covers Well:
- Streptococci (including S. pyogenes)
- Staphylococci (including MSSA)
- Anaerobes (Prevotella, Porphyromonas, Fusobacterium, Peptostreptococcus)—the dominant organisms in both pedicure-related skin infections and dental abscesses 1, 3
Critical Gap in Coverage:
Clindamycin misses Pasteurella multocida and some gram-negative organisms 1. However, this is not relevant for your patient since:
- Pedicure infections typically involve skin flora (staph/strep) and water-borne organisms
- Dental infections are predominantly anaerobic with some streptococci 3
- Pasteurella is only relevant for animal bites, not applicable here
Alternative Options if Clindamycin Fails
If the patient doesn't improve within 48-72 hours on clindamycin, consider:
Moxifloxacin 400 mg daily: Provides broad coverage including anaerobes as monotherapy 1. This fluoroquinolone covers both aerobic and anaerobic pathogens without beta-lactam cross-reactivity.
Levofloxacin 750 mg daily PLUS metronidazole 500 mg three times daily: The combination covers gram-positives, gram-negatives, and anaerobes 1. This is particularly useful if there's concern about resistant organisms.
Important Caveats
Regarding the "Rash":
- Not all rashes are true allergies: If this was a mild, non-urticarial rash without angioedema, respiratory symptoms, or systemic features, it may represent a non-IgE-mediated reaction rather than true allergy
- Consider allergy testing: If the rash was mild and delayed (>72 hours after starting), the patient may tolerate cephalosporins or could be "de-labeled" after proper evaluation 4
- Immediate action required: Given the dual infections, don't delay treatment waiting for allergy clarification—start clindamycin now
Clindamycin-Specific Warnings:
- Monitor for C. difficile colitis: Clindamycin carries higher risk of antibiotic-associated diarrhea and pseudomembranous colitis 5. Counsel the patient to report severe diarrhea immediately.
- Recent resistance concerns: Some studies show increasing clindamycin resistance rates 4, but it remains effective in most cases when source control (drainage, dental extraction) is performed
Treatment Duration and Adjunctive Measures
- Duration: 5 days minimum, extend to 7 days if not improved 1
- Source control is paramount:
- Elevation: Keep the affected foot elevated to reduce swelling 1
- Dental referral: Urgent dental evaluation is critical since you cannot localize the tooth—imaging (periapical radiographs or panorex) is needed to identify the source
Clinical Monitoring
Reassess at 48-72 hours for:
- Reduction in pain, swelling, and erythema
- Resolution of fever (if present)
- Ability to bear weight (for toe infection)
- Improvement in oral symptoms
If no improvement or worsening, obtain cultures and consider IV therapy with vancomycin plus piperacillin-tazobactam for broader coverage 1.